Pravastin put to test

January 23, 1998

Investigators from Glasgow University, Glasgow Royal Infirmary and Cork and Leiden Universities are starting the first study of the effects of pravastin, a medication widely prescribed to prevent heart attacks in people aged 70 and over. The study, being led by James Shepherd, Glasgow University's professor of pathological biochemistry, will enrol 5,500 patients from the United Kingdom, Ireland and the Netherlands.

Register to continue

Why register?

  • Registration is free and only takes a moment
  • Once registered, you can read 3 articles a month
  • Sign up for our newsletter
Please Login or Register to read this article.


Featured jobs